English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52847931    ???header.onlineuser??? :  736
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hsu c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 781-830 of 881  (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2009-09-15 Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL
國家衛生研究院 2009-05-20 Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application Kuo, S;Chen, L;Wu, M;Hsu, C;Lin, C;Hsu, P;Yeh, K;Tzeng, Y;Cheng, A
國家衛生研究院 2009-04-24 Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL
國立臺灣大學 2009-04 Frame Misalignment: Interpreting the Implementation of Information Systems Security Certification in an Organization Hsu, C.
國立臺灣大學 2009-03 The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. Lin, ZZ; Hsu, HC; Hsu, CH; Yeh, PY; Huang, CY; Huang, YF; Chen, TJ; Kuo, SH; Hsu, C; Hu, FC; Jeng, YM; Chung, Y; Cheng, AL.
國家衛生研究院 2009-02 Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival Shen, YC;Hu, FC;Jeng, YM;Chang, YT;Lin, ZZ;Chang, MC;Hsu, C;Cheng, AL
國家衛生研究院 2009 Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis Hsu, C;Shen, Y;Chen, L;Cheng, C;Hu, F;Cheng, A
高雄醫學大學 2009 軟珊瑚Nephthea erecta and N. chabrolizp 分離純化的sesquiterpenes and norergosterol  鄭旭益;溫世宏;邱素芬;王雙桂;戴昌鳳;杜昌益  ; Cheng SY;Huang YC;Wen ZH;Chiou SF;Wang SK;Hsu C;Dai CF;Duh CY
國立臺灣大學 2009 Creating Experience Economy in E-Commerce Chang, W.; Yuan, S.T.; Hsu, C.
臺大學術典藏 2009 Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy Chen P.-J.; Cheng A.-L.; SHU-CHEN WEI; Hsu C.
國家衛生研究院 2008-12 Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu, C;Kuo, SH;Hu, FC;Cheng, AL;Shih, JY;Yu, CJ;Lin, CC;Huang, TC;Yang, PC;Yang, CH
國立政治大學 2008-12 Teachers’ perceptions of the dimensions and implementation of technology leadership of principals in Taiwanese elementary schools Chang, I.;秦夢群;Hsu, C.; Chang, I.;Chin, J.M.;Hsu, C.
元智大學 2008-05 線上遊戲設計: 分析架構與個案探討 邱昭彰; Jen, E F; Hsu, C.
國家衛生研究院 2008-03 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Chao, TY; Liu, TW; Cheng, AL; Chen, PJ
國立臺灣大學 2008-03 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial. Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ
國立臺灣大學 2008-03 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by international prognostic scoring system, cytogenetic and genetic studies. Huang, TC; Ko, BS; Hsu, C; Chen, CY; Tsay, W; Tang, JL; Huang, SY; Yao, M; Chen, YC; Shen, MC; Wang, CH; Tien, HF
國家衛生研究院 2008 Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment Hsu, C;Chen, LT;Chao, Y;Fan, HH;Shen, YC;Cheng, AL
臺北醫學大學 2008 Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. 鄭建睿; Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
臺大學術典藏 2008 Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment CHIH-HSIN YANG; Yang P.-C; Cheng A.-L; Lin C.-C; Hsu C.-H; Yu C.-J; Chang Y.-C; Chih-Hsin Yang;Yang P.-C;Cheng A.-L;Lin C.-C;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C
臺大學術典藏 2008 Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers Hsu C.; JIN-YUAN SHIH; Yang C.-H.; Yu C.-J.; Lo Y.; Chen J.-P.
臺大學術典藏 2008 Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer Jan I.-S.; Wong J.-M.; Tsao P.-N.; Chang Y.-T.; Chang M.-C.; SHU-CHEN WEI; Tien Y.-W.; Hsu C.; Liang P.-C.
臺大學術典藏 2008 Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer Wong J.-M.; Jan I.-S.; PO-NIEN TSAO; Liang P.-C.; Hsu C.; Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.
臺大學術典藏 2008 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies Tien H.-F.; Shen M.-C.; Wang C.-H.; Chen Y.-C.; MING YAO; Huang S.-Y.; Tsay W.; Hsu C.; Chen C.-Y.; Tang J.-L.; Ko B.-S.; Huang T.-C.
臺大學術典藏 2008 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Chen P.-J.; Cheng A.-L.; Liu T.-W.; Chao T.-Y.; HWEI-FANG TIEN; Wu H.-B.; Li C.-C.; Liao Y.-M.; Young J.-H.; Chang M.-C.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; Hsu C.; Hsiung C.A.
臺大學術典藏 2008 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies Tien H.-F.; Wang C.-H.; Shen M.-C.; Chen Y.-C.; Yao M.; Huang T.-C.; BOR-SHENG KO; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.
國立臺灣大學 2007-12 Strategic planning of developing automatic optical inspection (AOI) technologies in Taiwan Hsu, C.; Fan, K.C.
中原大學 2007-08 Photoluminescence Studies in Anodic Aluminum Oxide Membranes Yang, M. D.;Chen, K. W.;Shen, J. L.;Hsu, C.
國家衛生研究院 2007-05 Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result Liang, PC; Ch'ang, HJ; Hsu, C; Tseng, SS; Shih, TTF; Liu, TW
元智大學 2007-05 Mining three-dimensional anthropometric body surface scanning data for hypertension detection 邱昭彰; Hsu, G; Hsu, P.; Hsu, C.
國立臺灣大學 2007-03 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Chang, YT; Hsu, C; Jeng, YM; Chang, MC; Wei, SC; Wong, JM
國立臺灣大學 2007-02 A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer. Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH.
國立臺灣大學 2007-02 A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer. Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH.
國家衛生研究院 2007 A prospective comparative study of prophylactic or therapeutic use of lamivudine for chemotherapy-associated hepatitis B (HBV) reactivation in nowhodgkin's lymphoma (NHL) patients Hsu, C;Hsiung, CA;Su, LJ;Hwang, WS;Wang, MC;Lin, SF;Lin, TH;Hsiao, HH;Young, JH;Chang, MC;Huang, MJ;Liao, YM;Li, CC;Wu, HB;Chao, TY;Liu, TW;Cheng, AL;Chen, PJ
臺北醫學大學 2007 The molecular events occur during MK-801-induced cytochrome oxidase subunit II down-regulation in GT1-7 cells. 李文森; Lee TY; Tsai KL; Lee WS; Hsu C
臺大學術典藏 2007 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Chang, YT;Hsu, C;Jeng, YM;Chang, MC;Wei, SC;Wong, JM; Chang, Y.-T. and Hsu, C. and Jeng, Y.-M. and Chang, M.-C. and Wei, S.-C. and Wong, J.-M.; Chang, YT; YUNG-MING JENG; YU-TING CHANG; Hsu, C; Jeng, YM; Chang, MC; Wei, SC; Wong, JM
臺大學術典藏 2007 Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial Yang C.-H.;Cheng A.-L;Hsu W.-L;Hsu C.-H;Hsu C;Chia-Chi Lin; Chia-Chi Lin; Hsu C; Hsu C.-H; Hsu W.-L; Cheng A.-L; Yang C.-H.
臺大學術典藏 2007 Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result Liang P.-C.; Ch'ang H.-J.; Hsu C.; Tseng S.S.; TIFFANY TING-FANG SHIH; Wu Liu T.
臺大學術典藏 2007 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Chang Y.-T.; Hsu C.; Jeng Y.-M.; Chang M.-C.; SHU-CHEN WEI; Wong J.-M.
元智大學 2006-12 Mining Flow-time in Wafer Manufacturing Processes using Constraint-Based Evolutionary Regression Trees 張百棧; 邱昭彰; Hsu, P.; Hsu, C.
國立臺灣大學 2006-09 CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma Su, M. C.; Hsu, C.; Kao, H. L.; Jeng, Y. M.
國家衛生研究院 2006-05 Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT
國家衛生研究院 2006-05 Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis Hsu, C;Shen, YC;Cheng, CC;Hong, RL;Chang, CJ;Cheng, AL
國家衛生研究院 2006-03 Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT
國家衛生研究院 2006 The impact of the tobacco market opening on smoking status in Taiwan: Findings from a secular smoking rates analysis Hsu, C;Lord, A;Tseng, T;Chen, T
國家衛生研究院 2006 The interplay of hNinein and Astrin- hNinein is required for targeting Spindle-associated protein Astrin to the centrosome Cheng, T;Hsiao, Y;Lin, C;Hsu, C;Chang, M;Lee, C;Yu, RC;Huang, CF;Howng, S;Hong, Y
臺北醫學大學 2006 17b-Estradiol Inhibits Subarachnoid Hemorrhage-Induced iNOS Gene Expression by Interfering with the Nuclear Factor Kappa B Transactivation. 李文森; Shih HC; Lin CL; Lee TY; Lee WS; Hsu C;
臺北醫學大學 2006 Predictors of Recurrent Stroke in African Americans 許重義; Ruland S; Richardson D; Hung E; Brorson JR; Cruz-Flores S; Felton WL 3rd; Ford-Lynch G; Helgason C; Hsu C;
高雄醫學大學 2006 雌二醇經由干擾NFkB抑制因蜘蛛膜下腔出血引起的iNOS基因表現  施慧娟;林志隆;李姿瑩;李文森;許勤 ; Shih HC;Lin CL;Lee TY;Lee WS;Hsu C 
國立臺灣大學 2006 Rating Certificate Authorities: a market approach to the Lemons problem Backhouse, J.; Baptista, J.; Hsu, C.
國立臺灣大學 2006 Circuits of Power in Creating de jure Standards: Shaping the International Information Systems Security Standard Backhouse, J; Hsu, C.; Silva, L.

Showing items 781-830 of 881  (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page